Published on August 6, 2009
EXHIBIT 32.1
CERTIFICATION PURSUANT
TO
18 U.S.C. § 1350
AS ADOPTED PURSUANT
TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
In connection with the Quarterly Report
on Form 10-Q of Novelos Therapeutics, Inc., (the “Company”) for the quarter
ended June 30, 2009, as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), we, Harry S. Palmin, President and Chief Executive
Officer of the Company, and Joanne M. Protano, Vice President, Chief Financial
Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to our
knowledge, that:
1) The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
2) The information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
|
/s/ Harry S.
Palmin
|
||
|
Harry S.
Palmin
|
||
|
President, Chief Executive Officer
(Principal Executive Officer)
|
||
|
Date: August 6,
2009
|
||
|
/s/ Joanne M.
Protano
|
||
|
Joanne M.
Protano
|
||
|
Chief Financial Officer (Principal
Financial and Accounting Officer)
|
||
|
Date: August 6,
2009
|
||